Both Jio Financial Services and Allianz Europe each subscribed 32,00,50,000 equity shares at ₹10 each in the joint venture, a rights issue that brought in fresh capital.
Jio’s aggregate investment in the venture now stands at ₹375 crore, a 23% rise since its initial ₹300 crore stake disclosed earlier this year. The transaction was a related‑party deal, executed on an arm‑s length basis with no promoter or group company interest.
On the BSE, Jio shares closed at ₹216.60, down 0.60% from the previous close, reflecting a muted market reaction to the capital infusion. Analysts note that the share price dip is likely a short‑term correction rather than a sign of underlying distress.
The JV, incorporated in May, is poised to launch a general insurance portfolio, including health insurance, pending regulatory approvals. Jio’s CEO, Amitabh Jaiswal, said the partnership aims to leverage Allianz’s global expertise to capture a growing Indian insurance market.
Looking ahead, Jio will likely seek approvals from the Insurance Regulatory & Development Authority of India, while the company has scheduled its Q3 earnings call for next month. Investors will watch the guidance closely for any shift in capital allocation or expansion plans.